Autoimmune polyglandular syndrome type 3
https://doi.org/10.21886/2219-8075-2020-11-4-78-83
Abstract
Autoimmune polyglandular syndrome type 3 (APS type 3) is a combination of autoimmune thyroid damage in combination with one or more autoimmune endocrine or non-endocrine diseases. It is represented by three subtypes: APS 3A (graves ‘ Disease, or Hashimoto’s thyroiditis and type 1 diabetes mellitus), APS 3B (autoimmune thyroid disease and pernicious anemia), APS 3C (autoimmune thyroid disease and vitiligo, alopecia, and/or other organ-specific autoimmune diseases). Clinical observations of patients with type 3 APS are presented: characteristic clinical syndromes and clinical and laboratory characteristics of patients. These clinical examples demonstrate the importance of thorough examination, alertness and knowledge of endocrinologists about the possibility of developing polyglandular lesions of the endocrine system, the importance of timely prescribed treatment and interdisciplinary interaction of doctors.
About the Authors
G. R. Gazizova
Kazan State Medical University
Russian Federation
Russian Federation
Cand. Sci. (Med.); Associate Professor of the Endocrinology Department,
Kazan
M. R. Shaydullina
Kazan State Medical University;
Children’s clinical Republican hospital
Russian Federation
Russian Federation
Cand. Sci. (Med.); associate professor of the Department of endocrinology;
physician of the endocrinology Department,
Kazan
F. V. Valeeva
Kazan State Medical University
Russian Federation
Russian Federation
Dr. Sci. (Med.), Professor of the Endocrinology Department,
Kazan
A. I. Galieva
Kazan State Medical University
Russian Federation
Russian Federation
resident of the Department of endocrinology,
Kazan
References
1. Troshina E. A., Larina A. A., Terekhova M. A. autoimmune polyglandular syndrome of adults: molecular genetic and clinical characteristics (lecture). Consilium Medicum. 2019; 21 (4): 91-96. DOI: 10.26442/20751753.2019.4.190361
2. Mackay IR, Rosen FS, Klein J, Sato A. The HLA System. New England Journal of Medicine. 2000;343(10):702-709, doi: 10.1056/nejm200009073431006
3. Golden B, Levin L, Ban Y, Concepcion E, Greenberg DA, Tomer Y. Genetic Analysis of Families with Autoimmune Diabetes and Thyroiditis: Evidence for Common and Unique Genes. The Journal of Clinical Endocrinology & Metabolism. 2005;90(8):4904-4911. doi: 10.1210/jc.2004-2236
4. Brent GA. Graves' Disease. New England Journal of Medicine. 2008;358(24):2594-2605. doi: 10.1056/NEJMcp0801880
5. Sozaeva L. S., Makazan N. V., Nikankina L. V., Malysheva N. M., kuvaldina E. V., Kareva M. A., Orlova E. M., Peterkova V. A. Determination of autoantibodies to 21-hydroxylase in the diagnosis of primary autoimmune adrenal gland. Problems of endocrinology (archive until 2020). 2019;65(6):466-473. https://doi.org/10.14341/probl12106
Review
For citations:
Gazizova G.R., Shaydullina M.R., Valeeva F.V., Galieva A.I. Autoimmune polyglandular syndrome type 3. Medical Herald of the South of Russia. 2020;11(4):78-83. (In Russ.) https://doi.org/10.21886/2219-8075-2020-11-4-78-83
Views:
3275
Email this article 